Gender, Depressive Symptoms, Chronic Medical Conditions, and Time to First Psychiatric Diagnosis among American Older Adults.

Chronic medical conditions depressive symptoms gender

Journal

International journal of preventive medicine
ISSN: 2008-7802
Titre abrégé: Int J Prev Med
Pays: Iran
ID NLM: 101535380

Informations de publication

Date de publication:
2019
Historique:
received: 10 12 2015
accepted: 11 04 2018
entrez: 6 3 2020
pubmed: 7 3 2020
medline: 7 3 2020
Statut: epublish

Résumé

To test whether gender moderates the effects of baseline depressive symptoms and chronic medical conditions (CMCs) on risk of receiving subsequent psychiatric diagnosis among older adults. Data came from ten waves of the Health and Retirement Study, a nationally representative longitudinal study. We followed 9794 individuals older than 52 years without any diagnosed psychiatric disorder at baseline for up to 18 years. Baseline depressive symptoms and CMC were the predictors, time to receiving an emotional diagnosis was the outcome, baseline demographics and socioeconomics were controls, and gender was the moderator. We used Cox proportional hazards models for data analysis. In the pooled sample, female gender increased the effect of baseline depressive symptoms (hazard ratio [HR], 1.58; 95% confidence interval [CI], 1.26-2.00) and reduced the effect of baseline CMC (HR, 0.78; 95% CI, 0.63-0.97) on time to receiving a psychiatric diagnosis. Among men, baseline depressive symptoms (HR, 2.36; 95% CI, 1.87-2.97) increased and baseline CMC (HR, 0.81; 95% CI, 0.69-0.95) decreased time to receiving a psychiatric diagnosis. Among women, depressive symptoms (HR, 1.49; 95% CI, 1.21-1.83) but not CMC (HR, 1.06; 95% CI, 0.91-1.23) were associated with time to receiving a psychiatric diagnosis over time. Men and women differ in how depressive symptoms and CMC influence their risk of receiving a psychiatric diagnosis over time. Depressive symptoms are more salient promotor for men than women while CMC is only a barrier for men.

Sections du résumé

BACKGROUND BACKGROUND
To test whether gender moderates the effects of baseline depressive symptoms and chronic medical conditions (CMCs) on risk of receiving subsequent psychiatric diagnosis among older adults.
METHODS METHODS
Data came from ten waves of the Health and Retirement Study, a nationally representative longitudinal study. We followed 9794 individuals older than 52 years without any diagnosed psychiatric disorder at baseline for up to 18 years. Baseline depressive symptoms and CMC were the predictors, time to receiving an emotional diagnosis was the outcome, baseline demographics and socioeconomics were controls, and gender was the moderator. We used Cox proportional hazards models for data analysis.
RESULTS RESULTS
In the pooled sample, female gender increased the effect of baseline depressive symptoms (hazard ratio [HR], 1.58; 95% confidence interval [CI], 1.26-2.00) and reduced the effect of baseline CMC (HR, 0.78; 95% CI, 0.63-0.97) on time to receiving a psychiatric diagnosis. Among men, baseline depressive symptoms (HR, 2.36; 95% CI, 1.87-2.97) increased and baseline CMC (HR, 0.81; 95% CI, 0.69-0.95) decreased time to receiving a psychiatric diagnosis. Among women, depressive symptoms (HR, 1.49; 95% CI, 1.21-1.83) but not CMC (HR, 1.06; 95% CI, 0.91-1.23) were associated with time to receiving a psychiatric diagnosis over time.
CONCLUSIONS CONCLUSIONS
Men and women differ in how depressive symptoms and CMC influence their risk of receiving a psychiatric diagnosis over time. Depressive symptoms are more salient promotor for men than women while CMC is only a barrier for men.

Identifiants

pubmed: 32133100
doi: 10.4103/ijpvm.IJPVM_333_15
pii: IJPVM-10-182
pmc: PMC6826688
doi:

Types de publication

Journal Article

Langues

eng

Pagination

182

Informations de copyright

Copyright: © 2019 International Journal of Preventive Medicine.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Soc Sci Med. 2001 Oct;53(7):865-78
pubmed: 11522134
Aust N Z J Psychiatry. 2005 Oct;39(10):921-31
pubmed: 16168020
Soc Sci Med. 1999 May;48(10):1363-72
pubmed: 10369437
Am J Psychiatry. 2002 Jun;159(6):1051-2
pubmed: 12042198
Br J Psychiatry. 2005 Apr;186:297-301
pubmed: 15802685
J Adv Nurs. 2005 Mar;49(6):616-23
pubmed: 15737222
Depress Anxiety. 2015 Nov;32(11):853-60
pubmed: 25903117
Health Rep. 2011 Jun;22(2):41-7
pubmed: 21848132
Soc Sci Med. 2002 Jan;54(1):1-10
pubmed: 11820673
Int Psychogeriatr. 2013 Mar;25(3):374-81
pubmed: 23217245
J Fam Pract. 2000 Feb;49(2):147-52
pubmed: 10718692
J Ment Health Policy Econ. 2004 Sep;7(3):107-25
pubmed: 15478990
Soc Psychiatry Psychiatr Epidemiol. 2010 Feb;45(2):153-63
pubmed: 19381427
J Womens Health (Larchmt). 2006 Dec;15(10):1205-13
pubmed: 17199461
J Am Coll Health. 2010;59(2):110-6
pubmed: 20864437
J Health Soc Behav. 1981 Mar;22(1):49-64
pubmed: 7240706
Soc Psychiatry Psychiatr Epidemiol. 2015 Jul;50(7):1089-95
pubmed: 25788391
Arch Gen Psychiatry. 2007 Apr;64(4):485-94
pubmed: 17404125
J Health Soc Behav. 1987 Jun;28(2):171-83
pubmed: 3611703
Psychol Med. 2014 Apr;44(6):1303-17
pubmed: 23931656
Am Psychol. 2003 Jan;58(1):5-14
pubmed: 12674814
Am J Community Psychol. 1987 Aug;15(4):403-17
pubmed: 3673952
Am J Public Health. 2003 Jul;93(7):1076-9
pubmed: 12835185
J Manag Care Pharm. 2008 Apr;14(3 Suppl):2-6
pubmed: 18439060
J Womens Health Gend Based Med. 2001 Sep;10(7):689-98
pubmed: 11571099
J Womens Health (Larchmt). 2010 Oct;19(10):1925-32
pubmed: 20831429
Singapore Med J. 2007 May;48(5):385-91
pubmed: 17453094
Soc Sci Med. 1999 Oct;49(8):1061-74
pubmed: 10475670
Aging Ment Health. 2006 Nov;10(6):574-82
pubmed: 17050086
J Behav Health Serv Res. 2009 Jul;36(3):372-84
pubmed: 19252987
J Health Serv Res Policy. 2000 Oct;5(4):237-49
pubmed: 11184961
J Affect Disord. 2002 Sep;71(1-3):1-9
pubmed: 12167495
BMC Psychiatry. 2014 May 09;14:135
pubmed: 24884891
J Child Psychol Psychiatry. 2006 Aug;47(8):840-8
pubmed: 16898998
J Womens Health (Larchmt). 2012 Jun;21(6):666-73
pubmed: 22313026
Rev Panam Salud Publica. 2002 May-Jun;11(5-6):365-73
pubmed: 12162833
Am J Public Health. 2010 Dec;100(12):2450-6
pubmed: 20966380
Psychosom Med. 2000 May-Jun;62(3):354-64
pubmed: 10845349
Arch Gen Psychiatry. 2002 Jan;59(1):77-84
pubmed: 11779286
Int J Epidemiol. 2014 Apr;43(2):576-85
pubmed: 24671021
Soc Sci Med. 2007 Mar;64(6):1216-30
pubmed: 17194514
Am J Geriatr Psychiatry. 2010 Nov;18(11):1036-44
pubmed: 20808088
Int Psychogeriatr. 1999 Jun;11(2):139-48
pubmed: 11475428

Auteurs

Shervin Assari (S)

Department of Family Medicine, Charles R Drew University of Medicine and Science, Los Angeles, CA, USA.
Department of Psychology, UCLA, Los Angeles, CA, USA.

Masoumeh Dejman (M)

Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Classifications MeSH